Rainer Wittig

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 7

Top Venues

Journal of biophotonics

Cell death & disease

Science signaling

RSC advances

Institute for Laser Technologies in Medicine and Metrology (ILM) at Ulm University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Institute for Laser Technologies in Medicine and Metrology (ILM) at Ulm University

Germany

PI :: Biology

R-Biopharm AG

Germany

Scientist :: Oncology

German Cancer Research Centre (DKFZ)

Germany

PhD Student, postdoctoral researcher :: Molecular Genome Analysis

German Cancer Research Center

Germany

Diploma Student :: Differentiation & Carcinogenesis in vitro

Publications

Florian Hausladen, Petra Kruse, Felicia Hessenberger, Thomas Stegmayer, Yu-Ting Kao, Wolf Seelert, Rosemarie Preyer, Marco Springer, Karl Stock, Rainer Wittig
Molecule transfer into mammalian cells by single sub-nanosecond laser pulses. Journal of biophotonics (2023)
Florian Hausladen, Petra Kruse, Felicia Hessenberger, Thomas Stegmayer, Yu-Ting Kao, Wolf Seelert, Rosemarie Preyer, Marco Springer, Karl Stock, Rainer Wittig
Molecule transfer into mammalian cells by single sub-nanosecond laser pulses. Journal of biophotonics (2023)
Roman Schmid, Juliane Kaiser, Ramona Willbold, Nomusa Walther, Rainer Wittig, Mika Linden
Towards a simple in vitro surface chemistry pre-screening method for nanoparticles to be used for drug delivery to solid tumours. Biomaterials science (2023)
Bozhena Caratti, Miray Fidan, Giorgio Caratti, Kristina Breitenecker, Melanie Engler, Naser Kazemitash, Rebecca Traut, Rainer Wittig, Emilio Casanova, Mohammad Reza Ahmadian, Jan P Tuckermann, Herwig P Moll, Ion Cristian Cirstea
The glucocorticoid receptor associates with RAS complexes to inhibit cell proliferation and tumor growth. Science signaling 15 (726) (2022)
Ramona Willbold, Katharina Wirth, Thomas Martini, Holger Sültmann, Christian Bolenz, Rainer Wittig
Correction: Excess hepsin proteolytic activity limits oncogenic signaling and induces ER stress and autophagy in prostate cancer cells. Cell death & disease 11 (2) (2020)
Ramona Willbold, Katharina Wirth, Thomas Martini, Holger Sültmann, Christian Bolenz, Rainer Wittig
Excess hepsin proteolytic activity limits oncogenic signaling and induces ER stress and autophagy in prostate cancer cells. Cell death & disease 10 (8) (2019)
Emma M Björk, Bernhard Baumann, Florian Hausladen, Rainer Wittig, Mika Linden
Cell adherence and drug delivery from particle based mesoporous silica films. RSC advances 9 (31) (2019)

Rainer Wittig.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Rainer Wittig